AAPM Medical Physics Practice Guideline 2.a: Commissioning and quality assurance of X-ray–based image-guided radiotherapy systems by Task Group et al.
AAPM Medical Physics Practice Guideline 2.a: 
Commissioning and quality assurance of X-ray–based 
image-guided radiotherapy systems
Task Group Authors: Jonas D. Fontenot, Hassaan Alkhatib, Jeffrey A. 
Garrett, Andrew R Jensen, Steven P. McCullough, Arthur J. Olch, Brent 
C. Parker, Ching-Chong Jack Yang, Lynne A. Fairobent, AAPM Staff
 
The American Association of Physicists in Medicine (AAPM) is a nonprofit profes-
sional society whose primary purposes are to advance the science, education, and 
professional practice of medical physics. The AAPM has more than 8,000 members 
and is the principal organization of medical physicists in the United States.
The AAPM will periodically define new practice guidelines for medical physics 
practice to help advance the science of medical physics and to improve the quality 
of service to patients throughout the United States. Existing medical physics practice 
guidelines will be reviewed for the purpose of revision or renewal, as appropriate, 
on their fifth anniversary or sooner.
Each medical physics practice guideline represents a policy statement by the 
AAPM, has undergone a thorough consensus process in which it has been sub-
jected to extensive review, and requires the approval of the Professional Council. 
The medical physics practice guidelines recognize that the safe and effective 
use of diagnostic and therapeutic radiology requires specific training, skills, and 
techniques, as described in each document. Reproduction or modification of the 
published practice guidelines and technical standards by those entities not provid-
ing these services is not authorized.
1.   Introduction
Image-guided radiation therapy (IGRT), in its many forms, is an important tool in improv-
ing the effectiveness of clinical radiation oncology. IGRT involves the use of patient images 
to localize and reposition the patient or delivery system prior to treatment to ensure that the 
therapeutic beam is correctly directed toward the target. IGRT imaging strategies have utilized 
X-rays, ultrasound, and other means. In particular, IGRT has been most commonly facilitated 
using X-rays, beginning with use of megavoltage (MV) portal and/or orthogonal setup images 
some decades ago. These images provide a means of evaluating the position of the treatment 
isocenter and field edges relative to the patient position. Because of the poor low-contrast reso-
lution of MV images, bony anatomy may be taken as a surrogate of the target volume, which 
is frequently soft-tissue-equivalent and not clearly visible within the image. However, as many 
studies have shown, the target volume can exhibit a different relative location to bony anatomy 
than expected. One solution to clinical scenarios in which improved soft-tissue targeting is 
desired was the introduction of in-room kilovoltage (kV) imaging systems. Such systems have 
included computed tomography (CT) scanners located within the treatment room (e.g., “CT-on-
rails”) and kV imaging systems affixed to the floor/ceiling or to the linear accelerator gantry 
itself. These systems have provided improved low-contrast localization of soft-tissue targets 
and — in the case of in-room CT scanners and gantry-mounted imaging systems — allowed 
for acquisition of pretreatment volumetric images. 
The specific choice and application of IGRT strategy depends on the complexity and require-
ments of the treatment in question. It may serve as an enhancement to an established technique 
(as in the case of three-dimensional conformal radiation therapy or intensity-modulated   radiation 
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therapy) or as a necessary and critical component of the treatment process (as in the case of 
stereotactic body radiation therapy(1)). Currently, IGRT strategies are being used more than 
ever before, and various forms of IGRT have been, are, and will continue to be important tools 
in radiation therapy. The report of AAPM Task Group 104(2) provides an instructive overview 
the various uses of X-ray imaging in radiation therapy.
As the clinical treatment process continues to rely more heavily on IGRT strategies, the 
Qualified Medical Physicist (QMP) is under increasing pressure to maintain patient safety and 
treatment quality through quality assurance programs that are in step with the rapid pace of 
technological development. Many clinical practice environments now utilize treatment delivery 
systems with one or more IGRT systems that fall under the responsibility of the QMP. A variety 
of guidance documents and task groups reports have been issued that include additional rec-
ommendations for commissioning and quality assurance of IGRT systems.(2-9) However, these 
reports do not clearly delineate best practice from minimum practice standards. 
a.  Goals and Rationale
  This document is part of a series of medical physics practice guidelines commissioned 
by the American Association of Physicists in Medicine (AAPM) intended to succinctly 
state the minimum acceptable standards for various aspects of clinical medical physics. 
While implementation of robust and comprehensive quality assurance programs recom-
mended in other reports from the AAPM is encouraged, the purpose of this particular 
report is to describe the minimum acceptable practice standards for the commissioning 
and quality assurance of X-ray–based image-guidance systems utilized in radiotherapy. 
This document is not intended to replace or revise previous AAPM Task Group Reports, 
but to assist the QMP in establishing and maintaining a safe and effective IGRT program 
by providing an overview of the minimum requirements and needs of X-ray–based IGRT 
systems. Indeed, the reader is referred to the appropriate technical reference documents 
or task group reports in instances when additional recommendations beyond minimum 
practice guidelines are desired.(1-8) Finally, the standards and procedures described in this 
document are applicable to the imaging guidance system insofar as its resulting images 
are used to position the patient and/or localize the target volume. Use of IGRT system 
hardware and software for other purposes, such as dose calculation, are beyond the scope 
of this report. Technologies covered by these guidelines include:
•   Gantry-mounted two-dimensional MV imaging systems 
•   Gantry-mounted three-dimensional MV imaging systems 
•   Gantry-mounted two-dimensional kV imaging systems 
•   Gantry-mounted three-dimensional kV imaging systems 
•   Room-mounted two-dimensional kV imaging systems 
•   Room-mounted three-dimensional kV imaging systems
  In this context, “gantry-mounted” imaging systems are those in which the mechanical 
movement of the imaging hardware is coupled with mechanical movement of the treatment 
delivery device (e.g., Varian/Elekta/Siemens on-board kV imaging systems, electronic 
portal MV imaging systems, TomoTherapy megavoltage CT, etc.). “Room-mounted” 
systems include all imaging systems not coupled with the treatment delivery device (e.g., 
ExacTrac, CyberKnife, in-room CT, etc.). Fluoroscopy modes are also within the scope 
of this report.
b. Intended Users
  The intended users of this report are QMPs who seek to understand the technical require-
ments of clinical implementation and quality assurance of a safe IGRT practice, and 
administrators interested in the resources required for IGRT.
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2.	 Definitions	and	Abbreviations
•   CBCT – cone-beam computed tomography
•   IGRT – image-guided radiotherapy
•   kV - kilovoltage
•   MV - megavoltage
•   OIS - oncology information system
•   QA - quality assurance
•   TPS - treatment planning system
3.	 Staff	Qualifications	and	Responsibilities
Implementation of a successful IGRT program requires contributions from each member of the 
treatment team. Recommendations for staff qualifications and responsibilities are consistent 
with those described by the ACR-ASTRO practice guideline for clinical use of IGRT.(9)
a.  Medical Physicist — The qualified medical physicist (QMP) must be competent to 
practice independently in the subfield of therapeutic radiological physics. The individual 
must be certified either by the American Board of Radiology, American Board of Medical 
Physicists, or the Canadian College of Medical Physicists. Responsibilities of the quali-
fied medical physicist in an IGRT program include:
•   Acceptance testing and commissioning
•   Implementing and managing a quality assurance program
•   Developing and implementing standard operating procedures (including imaging 
protocols and repositioning thresholds)
  The QMP may be assisted by medical physics residents or medical physicist assistants 
with these responsibilities provided 1) these individuals have been appropriately trained 
to perform the assigned tasks, and 2) the QMP provides general supervision of all work 
performed.
b. Radiation Oncologist — The radiation oncologist should meet qualifications outlined in 
the ACR-ASTRO practice guideline for clinical use of IGRT.(10) In short, the responsibili-
ties of the radiation oncologist in an IGRT program include:
•   Specifying patient positioning procedures
•   Specifying imaging modalities and frequencies
•   Identifying registration targets and repositioning thresholds
•   Conducting timely review of clinical IGRT images
•   Conducting regular reviews of the IGRT program 
•   Implementing and managing a quality assurance program
•   Developing and implementing standard operating procedures (including imaging 
protocols and repositioning thresholds)
c.  Medical Dosimetrist — The medical dosimetrist should meet the qualifications outlined 
in the Scope of Practice of a Medical Dosimetrist approved by the Board of Directors 
of the American Association of Medical Dosimetrists.(11) Responsibilities of the medical 
dosimetrist or treatment planner in an IGRT program include:
•   Creating and transferring to the OIS all patient-specific data necessary for IGRT 
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d. Radiation Therapist — The radiation therapist should meet the qualifications outlined 
in Radiation Therapy Practice Standards issued by the American Society of Radiologic 
Technologists.(12) Responsibilities of the radiation therapist in an IGRT program 
include:
•   Understanding the use of positioning devices in IGRT
•   Preparing the IGRT system for acquisition of patient-specific positioning verification 
images
•   Implementing the IGRT treatment protocol under the supervision of the radiation 
oncologist and medical physicist
•   Acquiring positioning verification images for review by the radiation oncologist
•   Assisting in periodic review of the stability of the IGRT system (e.g., daily QA) 
e.  Information Technologist — It is important that each facility identify an individual that 
is responsible for providing and maintaining resources necessary for storing, archiving 
and retrieving images generated during IGRT. This may be accomplished by a dedicated 
Information Specialist or duties assigned to another team member. 
4.  Implementation Guidelines
a. Minimum required resources and equipment
i.	 Staffing
  Approximate time requirements needed for implementation, maintenance and quality 
assurance of each IGRT program type (per each IGRT system) are provided below. 
Estimates are provided as general reference values only, and are not intended to justify 
site-specific staffing models or physics time for specific billing codes. “Acceptance/
commissioning” includes all activities needed for IGRT program implementation, 
including documentation. “Documentation” refers to creation of a formal commission-
ing report, and drafting of policies and procedures specific to clinical use and routine 
quality assurance of IGRT (including creating QA forms and templates). “Ongoing 
support” includes all activities needed for maintenance of an established IGRT program 
(e.g., routine quality assurance, troubleshooting, upgrades, service/repairs).
1. Two-dimensional MV imaging systems
•   Acceptance/Commissioning/Documentation: 18–36 hours
•   Ongoing support: 25–50 hours annually
2.  Two-dimensional kV imaging systems
•   Acceptance/Commissioning/Documentation: 18–36 hours
•   Ongoing support: 25–50 hours annually
3.  Three-dimensional MV imaging systems
•   Acceptance/Commissioning/Documentation: 18–36 hours
•   Ongoing support: 100–125 hours annually 
4. Three-dimensional kV imaging systems
•   Acceptance/Commissioning/Documentation: 18–36 hours
•   Ongoing support: 100–125 hours annually
ii. Equipment
  Quality assurance phantoms and tools must provide reliable values of the measured 
parameters and can be used to judge whether tolerance criteria have been achieved. 
In many cases, manufacturers of IGRT systems provide quality assurance phantoms 
which can be used for quality assurance purposes. In-house and commercial phantoms 
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image analysis tools, may improve efficiency. At a minimum, quality assurance tools 
must be capable of assessing the following IGRT characteristics:
•   Image quality
•   Spatial accuracy (scaling)
•   Congruence of imaging and treatment isocenters
•   Accuracy of registration/couch movements
•   Imaging dose 
b.	Staff	training	
  Training for the operation of the IGRT system must be provided. The IGRT system vendor 
typically provides on-site training to the physicist and therapists for use of the equipment. 
Prior to initial use of IGRT, the treatment team should meet to discuss staff responsibili-
ties, clinical goals, and process workflows. The physicist should also review the image 
acquisition procedures with the therapists and radiation oncologists. In general, IGRT 
training will require additional dedicated staff time that is not included in the estimated 
time requirements of Section 4.a.1.
c.  Process descriptions
  Example procedures for each of the tests recommended in Table 1 are described below. 
The approximate time needed to complete each procedure is noted in parenthesis follow-
ing the process description. In some cases, customer acceptance procedures provided by 
the equipment vendor satisfactorily meet the stated practice standards; however, it is the 
responsibility of the QMP to judge the adequacy and completeness of all measurements 
needed for use of a particular IGRT system. It is important to note that these are only 
example procedures, and a variety of methods may be used to complete the recommended 
tests. Certain commercially available products are referred to by name. These references 
are for informational purposes only, and imply neither endorsement by the AAPM nor 
that these are the best or the only products available for the stated purpose.
i.   Customer acceptance procedures (all systems)
  The QMP must provide direct supervision during the acceptance testing process.(13)   
Customer acceptance tests procedures are intended to ensure that the imaging equip-
ment satisfies the performance requirements stated in the purchase agreement. In 
some cases, measurements completed as part of the acceptance procedures may 
also serve as components in establishing the routine quality assurance program. The 
vendor must demonstrate acceptable system performance. (Time: 8–16 hours)
ii.		 TPS	configuration	and	connectivity	(2D	systems)
  Digitally reconstructed radiographs (DRR) of test objects in various orientations are 
created with the treatment planning system and transferred (typically via DICOM 
interface) to the image guidance system. Proper display of the DRR image within 
the image-guidance software must be ensured. (Time: 3–4 hours)
iii.	 TPS	configuration	and	connectivity	(3D	systems)
  Reference CT image sets of test objects in various orientations are imported into 
the treatment planning system. Contours are added and the images and structures 
are transferred (typically via DICOM interface) to the image-guidance system. 
Proper display of the reference CT images and structures within the image-guidance 
software must be ensured. (Time: 3–4 hours)
iv.	 OIS	integration	and	connectivity	(2D	systems)
  Setup fields created for a test patient within the oncology information system are 
properly recognized by the imaging hardware and software when loaded. Acquired 
images are then assigned to the correct patient, if applicable. (Time: 2–3 hours)8    AAPM: Medical Physics Practice Guidelines  8
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v.		 OIS	integration	and	connectivity	(3D	systems)	
  Volumetric IGRT image fields (CBCT, MVCT, CT-on-rails) created for a test patient 
within the oncology information system are properly loaded and recognized by the 
imaging hardware and software. Acquired images are assigned to the correct patient, 
if applicable. (Time: 2–3 hours)
vi.	 Routine	QA	baselines	(all	systems)
  Measurements taken at the time of IGRT system commissioning which characterize 
IGRT system performance will serve as reference values for the routine QA program. 
See Table 1 for recommended QA tests requiring reference measurements. (Time: 
2–3 hours)
vii.	 IGRT	QA	program	documentation	(all	systems)
  All acceptance and commissioning procedures and results must be contained within 
a formal report. Furthermore, a formal policy for routine IGRT QA program and 
Ta b l e  1.  Recommended minimum practices for commissioning and QA of an IGRT system.
Acceptance Testing and Commissioning
Procedure 
  Customer acceptance procedures 
  TPS integration 
  OIS integration 
  Establish routine QA baselines 






  Imaging-treatment isocenter coincidence (SRS only)  1 mm
  Positioning/repositioning (SRS only)  1 mm
  Imaging-treatment isocenter coincidence (SBRT only)  2 mm
  Positioning/repositioning (SBRT only)  2 mm
 
Weekly
Imaging-treatment isocenter coincidence (non-SRS/SBRT)  2 mm
Positioning/repositioning (non-SRS/SBRT)  2 mm
 
Semi-annually




  2D MV   ± 1 cGy of baseline value
  2D kV (static imaging mode)  ± 3 mGy of baseline value
  2D kV (fluoroscopy mode)  ± 1 cGy/min of baseline value
  All 3D imaging modes   ± 1 cGy of baseline value
Image quality
     2D (spatial resolution, contrast)  Baseline value
     3D (uniformity, spatial resolution, contrast) 
 
Upgrade/Repair/Service
Verify / Reestablish QA baselines (as appropriate) 
SRS = stereotactic radiosurgery; SBRT = stereotactic body radiation therapy.9    AAPM: Medical Physics Practice Guidelines  9
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procedures for performing routine QA measurements must be developed. (Time: 
4–8 hours)
viii.	 Safety/interlocks	(all	systems)
  With image acquisition initiated, ensure beam termination occurs when the treatment 
room door is opened (if applicable) and when any termination keys are depressed. 
If images are to be acquired with the treatment room door open, then measure-
ments and calculations of exposure should be performed at the treatment console 
to ensure safe operating conditions. Also ensure that gantry rotation is terminated 
when touch guards are depressed. Verify that indicator lamps are illuminated during 
image acquisition (Time: 5 minutes)
ix.		 Contrast	(2D	kV	systems)	
  A phantom with low-contrast objects (such as the Leeds phantom) is placed on 
the treatment couch at isocenter. A planar kV image is acquired using a reference 
technique determined at the time of acceptance testing. The window and level are 
adjusted to reference values determined at the time of acceptance testing. The num-
ber of visible disks is recorded, with more indicating better low-contrast visibility. 
(Time: 15 minutes) 
x.		 Contrast	(2D	MV	systems)
  A phantom with low-contrast objects (such as the Las Vegas phantom) is placed on 
the treatment couch. A planar MV image is acquired using a reference technique 
determined at the time of acceptance testing. The window and level are adjusted to 
a reference value determined at the time of acceptance testing. The number of vis-
ible disks of largest diameter or frequency groups is recorded, with more indicating 
better low-contrast visibility. (Time: 15 minutes)
xi.		 Contrast	(3D	systems)
  An appropriate volumetric image quality phantom (such as a CT phantom) is posi-
tioned on the treatment table using the room lasers. A volumetric image is acquired 
using a reference technique determined at the time of acceptance testing. Either the 
difference in CT number of different materials within the phantom, or the number 
of visible low-contrast objects is recorded. (Time: 15 minutes)
xii.		 Spatial	resolution	(2D	kV	systems)
  A phantom with high-contrast objects (such as the Leeds phantom) is placed on 
the treatment couch. A planar kV image is acquired using a reference technique 
determined at the time of acceptance testing. The number of frequency groups that 
are clearly distinguished is recorded, with more frequency groups indicating better 
spatial resolution. (Time: 15 minutes)
xiii.		 Spatial	resolution	(2D	MV	systems)
  A phantom with high-contrast objects (such as the Las Vegas phantom) is placed 
on the treatment couch. A planar MV image is acquired using a reference technique 
determined at the time of acceptance testing. The number of visible disks of greatest 
contrast is recorded, with more disks indicating better spatial resolution. (Time: 15 
minutes)
xiv.		 Spatial	resolution	(3D	systems)
  An appropriate volumetric image quality phantom (such as the Catphan) is positioned 
on the treatment table using the room lasers. A volumetric image is acquired using 
a reference technique determined at the time of acceptance testing. The number of 
frequency groups that are clearly distinguished is recorded, with more frequency 
groups indicating better spatial resolution. (Time: 15 minutes)10    AAPM: Medical Physics Practice Guidelines  10
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xv.		 Scaling	(all	systems)
  A phantom of known dimensions is placed on the treatment table using the room 
lasers. A planar or volumetric image is acquired. Window and level are adjusted 
such that phantom is clearly visible. The distance between two objects of known 
separation in the horizontal and vertical axes is recorded and compared with the 
known distance. For 3D imaging systems, scaling must be measured in all 3 dimen-
sions. (Time: 10 minutes)
xvi.		 Uniformity	(3D	systems)
  An appropriate volumetric image quality phantom (such as the Catphan) is posi-
tioned on the treatment table using the room lasers. A volumetric image is recorded. 
The average pixel value over a region of interest at multiple locations (e.g., center,   
12 o’clock, and 3 o’clock) is recorded and compared. (Time: 15 minutes) 
xvii.	 Imaging-treatment	isocenter	coincidence	(2D	systems)
  A variety of methods may be used to verify congruence of imaging and treatment 
isocenters. Most of these techniques require alignment of a radiopaque marker 
(e.g., ball bearing, fiducial, or commercial device) to treatment isocenter via room 
lasers. Orthogonal or oblique images are then acquired. Congruence of imaging 
and treatment isocenters is verified by comparing the position of the markers with 
the center of the orthogonal/oblique images. (Time: 10–15 minutes)
xviii.	Imaging-treatment	isocenter	coincidence	(3D	systems)	
  A variety of methods may be used to verify congruence of imaging and treatment 
isocenters. Most of these techniques are usually coupled with the “positioning/
repositioning” test and begin with positioning of a radiopaque marker (ball bear-
ing, fiducial, or commercial device) on the treatment table with known offsets from 
isocenter. Volumetric IGRT images are then acquired and registered with reference 
images. The recommended couch shifts from the image registration software are 
recorded and applied, and coincidence of the imaging and treatment isocenters 
is assessed by 1) comparing the position of the marker with the room lasers, or   
2) comparing the coincidence of the marker with the center position of an acquired 
MV portal image, if available. (Time: 10–15 minutes)
xix.		 Positioning/Repositioning	(all	systems)
  A radiopaque marker is positioned on the treatment table with known offsets from 
isocenter. Images are acquired and registered with reference images. The recom-
mended couch shifts from the image registration software are recorded and applied. 
Proper functioning of the image registration software is verified by comparing the 
recommended couch shifts with the known offsets, while correct application of the 
shifts is assessed by comparing the position of the marker with the room lasers. 
(Time: 10–15 minutes)
xx.	 Imaging	dose	(3D	systems)
  Several different methods are currently used to characterize the dose from 3D IGRT 
systems. The traditional metric for dose from CT imaging, the computed tomog-
raphy dose index (CTDI), has been applied to IGRT imaging. More recently, the 
AAPM Task Group 111(9) report has introduced a new metric, the cumulative dose. 
These two different metrics use different measurement equipment and irradiation 
geometries to characterize the dose. 
      Measurement equipment used to measure CTDI includes a calibrated 100 mm 
long pencil ionization chamber and an appropriate phantom, one simulating a head 
and the other a large pelvis. For each imaging mode, the phantom that matches 
the mode’s target anatomy is used. The phantom is positioned at isocenter and the 11    AAPM: Medical Physics Practice Guidelines  11
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pencil chamber is centered in the phantom. The radiation field length must be con-
strained to be less than the active length of the pencil ionization chamber. For each 
imaging mode, measurements are repeated for the central and peripheral phantom 
locations. 
      Measurement equipment used to measure the cumulative imaging dose includes 
a Farmer-type ionization chamber calibrated in the appropriate energy range and 
several acrylic CTDI phantoms. For each imaging mode, the phantoms that match 
the mode’s target anatomy are used. The CTDI phantoms are abutted until their 
length exceeds the length of the radiation field. The phantom is centered at isoce-
nter and the Farmer chamber is centered in the phantom. For each imaging mode, 
measurements are repeated for the central and peripheral phantom locations. 
      Measured imaging dose must be documented and its management should be 
approached with the goal of keeping it as low as necessary to achieve clinically 
useful images. (Time: 15–60 minutes, depending on the number of techniques 
measured)
xxi.		 Imaging	dose	(2D	systems)
  Imaging dose from 2D kV systems is most typically characterized using entrance 
surface air kerma (skin exposure). Measurement equipment used to measure the 
entrance air kerma includes a calibrated ionization chamber and a phantom. The 
ionization chamber is placed between the source and the phantom in such a way 
as to minimize scatter radiation to the ionization chamber. The field size is set to 
cover the detector. A clinically relevant beam is delivered, and the air kerma rate 
is calculated for static and fluoroscopic imaging modes, respectively.
      Measured imaging dose should be documented and its management should be 
approached with the goal of keeping it as low as necessary to achieve clinically 
useful images. (Time: 15–60 minutes, depending on the number of techniques 
measured)
d.		Continuing	quality	improvement
  Ongoing review and audit of the IGRT program should occur at regular intervals. In 
particular, periodic review of clinical image registration, the use of appropriate imaging 
techniques/frequencies, adherence to stated QA programs, and revision of IGRT strategies 
based on pertinent changes in clinical practices should be assessed. 
5.   Recommendations
Recommended minimum practices for commissioning and QA of an IGRT system are shown 
in Table 1. Test frequencies and tolerance values were developed based on relevant AAPM 
Task Group reports and the experience of the MPPG members in relation to the stability and 
importance of each parameter to the IGRT process. Sample process descriptions are included in 
Section 5.c. The “baseline value” shown in the table refers to the IGRT system manufacturer’s 
minimum performance standard stated in the customer acceptance procedure documentation. 
If unavailable or not specified, then “baseline value” can be taken as the value measured at the 
time of commissioning. For example, most IGRT system manufacturers have stated performance 
specifications for image quality and, in such cases; those may serve as the tolerance values for 
routine QA measurements of image quality. However, most IGRT system manufacturers do 
not have stated performance specifications for imaging dose and, in such cases, the imaging 
dose measured at the time of commissioning may serve as the baseline value to which future 
measurements are compared. 
In general, the frequency of routine QA tests is proportional to the importance of their 
performance for the purpose of patient alignment. As such, evaluation of imaging-treatment 
isocenter coincidence and positioning/repositioning is considered critical. While daily checks 
of these parameters are preferred, weekly checks are considered acceptable for IGRT systems 12    AAPM: Medical Physics Practice Guidelines  12
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used with standard fractionation schemes. For IGRT systems used for SRS/SBRT, daily QA 
testing frequency must also be required on days when procedures are scheduled. 
The imaging dose from an IGRT system must be measured for at least one acquisition 
technique of each mode of clinical operation. For example, a gantry-mounted kV system used 
to acquire both 2D and 3D clinical images must have documented imaging doses for both 2D 
and 3D modes. If imaging dose is only measured for one acquisition technique, then the chosen 
technique should serve to provide the most conservative value (e.g., choose the acquisition 
technique that results in the greatest imaging dose). For 2D kV systems operated in fluoroscopy 
mode, the entrance exposure rate should be measured for the technique expected to produce 
the highest value. 
These recommendations must also be augmented with procedures required by state regula-
tions (such as measurement of X-ray tube voltage accuracy, where applicable). Furthermore, 
IGRT systems with known recurring problems should be subjected to more frequent QA at 
the discretion of the QMP. Annual end-to-end tests are also an effective method of assessing 
overall IGRT system accuracy, but are not required in this report.
6.   Conclusions
IGRT is a powerful and increasingly essential component of clinical radiation oncology prac-
tice. Proper use and quality assurance of clinical IGRT systems are of critical importance to 
maximizing the benefits and minimizing the risks of the technology. The minimum technical 
requirements for managing a clinical IGRT program stated in this document will help to achieve 
a more uniform standard of practice that improves the safety and quality of care of patients for 
whom IGRT is needed.
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